{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:13:15Z","timestamp":1793211195537,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["z-2014-03-2205"],"award-info":[{"award-number":["z-2014-03-2205"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cpt.2025.12.003","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T23:26:17Z","timestamp":1766273177000},"page":"362-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cancer therapy-induced cardiotoxicity: mechanisms, biomarkers, psychological stress, and emerging therapeutic strategies"],"prefix":"10.1016","volume":"4","author":[{"given":"Haiyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9114-9633","authenticated-orcid":false,"given":"Meiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2025.12.003_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2025.12.003_bib2","article-title":"Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors","volume":"10","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib3","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41467-020-15639-5","article-title":"Fatal heart disease among cancer patients","volume":"11","author":"Stoltzfus","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpt.2025.12.003_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029967","article-title":"Heart disease mortality in cancer survivors: a population-based study in Japan","volume":"12","author":"Gon","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpt.2025.12.003_bib5","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the european hematology association (EHA), the european society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpt.2025.12.003_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41569-024-01024-y","article-title":"Stress and cardiovascular disease: an update","volume":"21","author":"Vaccarino","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archinternmed.2009.179","article-title":"Psychological distress in long-term survivors of adult-onset cancer: results from a national survey","volume":"169","author":"Hoffman","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.585534","article-title":"Depression and anxiety in patients with cancer: a cross-sectional study","volume":"12","author":"Naser","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.cpt.2025.12.003_bib9","article-title":"Anxiety and depression in adult cancer patients: ESMO clinical practice guideline","volume":"8","author":"Grassi","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.cpt.2025.12.003_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/hm.HM-D-24-00040","article-title":"Impact of chronic psychological stress on cardiovascular disease risk: a narrative review","volume":"8","author":"Munir","year":"2024","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2025.12.003_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","article-title":"Cancer drugs and the heart: importance and management","volume":"34","author":"Suter","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpt.2025.12.003_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib13","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.amjcard.2016.07.049","article-title":"Prognostic significance of new-onset atrial fibrillation in patients with Non-Hodgkin\u2019s lymphoma treated with anthracyclines","volume":"118","author":"Amioka","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib15","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level","volume":"65","author":"Barac","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0284186X.2019.1711164","article-title":"Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer","volume":"59","author":"Dyhl-Polk","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425247.2013.752354","article-title":"Paclitaxel drug delivery systems","volume":"10","author":"Zhang","year":"2013","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.cpt.2025.12.003_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.critrevonc.2018.03.014","article-title":"Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system","volume":"126","author":"Babiker","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cpt.2025.12.003_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1345\/aph.10358","article-title":"Ischemic heart disease associated with vincristine and doxorubicin chemotherapy","volume":"35","author":"Calvo-Romero","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cpt.2025.12.003_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejca.2016.02.004","volume":"58","author":"Fridrik","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpt.2025.12.003_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biof.1301","article-title":"Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses","volume":"42","author":"Chowdhury","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.cpt.2025.12.003_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1078155214522314","article-title":"Cisplatin-induced bradycardia and the importance of the QT interval","volume":"21","author":"Schlumbrecht","year":"2015","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.cpt.2025.12.003_bib24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib25","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib26","article-title":"Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12872-023-03378-6","article-title":"Selective serotonin reuptake inhibitors regulate the interrelation between 5-HT and inflammation after myocardial infarction","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpt.2025.12.003_bib28","doi-asserted-by":"crossref","first-page":"50209","DOI":"10.18632\/oncotarget.16854","article-title":"Epidermal growth factor receptor (EGFR): a rising star in the era of precision medicine of lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cpt.2025.12.003_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.726008","article-title":"Incidence and risk of hypertension in cancer patients treated with atezolizumab and Bevacizumab: a systematic review and meta-analysis","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10549-019-05139-6","article-title":"Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction","volume":"175","author":"Hussain","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpt.2025.12.003_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/03008916221084362","article-title":"Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib","volume":"109","author":"Zhao","year":"2023","journal-title":"Tumori"},{"key":"10.1016\/j.cpt.2025.12.003_bib32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/jcm9051268","article-title":"Cardiovascular complications of systemic therapy in non-small-cell lung cancer","volume":"9","author":"Zaborowska-Szmit","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaccao.2019.10.006","article-title":"Osimertinib-induced cardiotoxicity: a retrospective review of the FDA adverse events reporting system (FAERS)","volume":"1","author":"Anand","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib34","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jtho.2021.07.030","article-title":"Pharmacovigilance analysis of cardiac toxicities associated with targeted therapies for metastatic NSCLC","volume":"16","author":"Waliany","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib35","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1042\/CS20200331","article-title":"Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"135","author":"Baik","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cpt.2025.12.003_bib37","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002771","article-title":"Pericardial disease in patients treated with immune checkpoint inhibitors","volume":"9","author":"Gong","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ejhf.2289","article-title":"Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis","volume":"23","author":"Rubio-Infante","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpt.2025.12.003_bib40","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2025.12.003_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413567","article-title":"Evolution of theories on doxorubicin-induced late cardiotoxicity-role of topoisomerase","volume":"25","author":"Szponar","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/cvr\/cvz023","article-title":"Cardioprotection in cancer therapy: novel insights with anthracyclines","volume":"115","author":"Raber","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2018.11.019","article-title":"Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity","volume":"126","author":"Llach","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib45","first-page":"44","article-title":"Fluoropyrimidine cardiotoxicity: time for a contemporaneous appraisal","volume":"18","author":"Upshaw","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxlet.2014.03.018","article-title":"A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives","volume":"227","author":"Lamberti","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cpt.2025.12.003_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1389200216666151103114926","article-title":"The role of the metabolism of anticancer drugs in their induced-cardiotoxicity","volume":"17","author":"Reis-Mendes","year":"2015","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.cpt.2025.12.003_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12883-016-0710-4","article-title":"The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer","volume":"16","author":"Dermitzakis","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cpt.2025.12.003_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12872-024-03814-1","article-title":"Paclitaxel-induced acute myocardial infarction: a case report and literature review","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpt.2025.12.003_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tox.2005.07.001","article-title":"dl-alpha-lipoic acid ameliorates cyclophosphamide induced cardiac mitochondrial injury","volume":"215","author":"Mythili","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.cpt.2025.12.003_bib52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.resp.2013.03.013","article-title":"Cardiotoxicity of cisplatin-based chemotherapy in advanced non-small cell lung cancer patients","volume":"187","author":"Demkow","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcp.2015.08.101","article-title":"Silencing of PKC-\u03b1, TRPC1 or NF-\u03baB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction","volume":"98","author":"Bodiga","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib55","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/cncr.10854","article-title":"Trastuzumab-associated cardiotoxicity","volume":"95","author":"Keefe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/sonc.2002.34051","article-title":"Trastuzumab cardiotoxicity: speculations regarding pathophysiology and targets for further study","volume":"29","author":"Schneider","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2023.06.019","article-title":"Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction","volume":"206","author":"Ye","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib58","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.7150\/thno.23207","article-title":"The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling","volume":"8","author":"Hsu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.cpt.2025.12.003_bib59","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.091415198","article-title":"A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function","volume":"98","author":"Giordano","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpt.2025.12.003_bib60","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cpt.2025.12.003_bib61","doi-asserted-by":"crossref","first-page":"1177003","DOI":"10.3389\/fphar.2023.1177003","article-title":"Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib62","first-page":"6","article-title":"Managing cardiotoxicity associated with immune checkpoint inhibitors","volume":"5","author":"Upadhrasta","year":"2019","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.887705","article-title":"Radiotherapy-induced cardiotoxicity: the role of multimodality cardiovascular imaging","volume":"9","author":"Podlesnikar","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00066-004-1138-0","article-title":"Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation","volume":"180","author":"Boerma","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.cpt.2025.12.003_bib65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American society of echocardiography and the european association of cardiovascular imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cpt.2025.12.003_bib66","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","article-title":"Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation","volume":"28","author":"Cardinale","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib67","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ehf2.13782","article-title":"Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters","volume":"9","author":"D\u00edaz-Ant\u00f3n","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpt.2025.12.003_bib68","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.21873\/invivo.13311","article-title":"Baseline troponin level and cardiac toxicity in HER2-positive early breast cancer patients receiving trastuzumab","volume":"37","author":"Canale","year":"2023","journal-title":"In Vivo"},{"key":"10.1016\/j.cpt.2025.12.003_bib69","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ijrobp.2021.07.035","article-title":"Assessment of prognostic value of high-sensitivity cardiac troponin T for early prediction of chemoradiation therapy-induced cardiotoxicity in patients with non-small cell lung cancer: a secondary analysis of a prospective randomized trial","volume":"111","author":"Xu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cpt.2025.12.003_bib70","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1515\/cclm-2022-1285","article-title":"Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance","volume":"61","author":"Clerico","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib71","first-page":"4992","article-title":"BNP as a marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer","volume":"18","author":"Lu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cpt.2025.12.003_bib72","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0284186X.2020.1842904","article-title":"Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab","volume":"60","author":"Andersson","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaccao.2019.11.013","article-title":"Immune checkpoint inhibitor-related adverse cardiovascular events in patients with lung cancer","volume":"1","author":"Chitturi","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib74","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.21037\/tcr-23-792","article-title":"Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study","volume":"12","author":"Chen","year":"2023","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.breast.2019.12.001","article-title":"ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer","volume":"49","author":"Aula","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.cpt.2025.12.003_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13121710","article-title":"Biomarkers and strain echocardiography for the detection of subclinical cardiotoxicity in breast cancer patients receiving anthracyclines","volume":"13","author":"Bhagat","year":"2023","journal-title":"J Personalized Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib77","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00280-015-2874-9","article-title":"Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients","volume":"76","author":"Bulten","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2022.03.010","article-title":"Genetics of cancer therapy-associated cardiotoxicity","volume":"167","author":"Kim","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib79","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ehf2.13735","article-title":"Novel molecular biomarkers of cancer therapy-induced cardiotoxicity in adult population: a scoping review","volume":"9","author":"Cartas-Espinel","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpt.2025.12.003_bib80","first-page":"286","article-title":"Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin\/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy","volume":"13","author":"Tan","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cpt.2025.12.003_bib81","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1038\/s41467-022-34917-y","article-title":"A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpt.2025.12.003_bib82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40959-022-00142-1","article-title":"A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research","volume":"8","author":"Brown","year":"2022","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.cpt.2025.12.003_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167969","article-title":"Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations","volume":"12","author":"Glinge","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.12.003_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060606","article-title":"let-7 microRNAs: their role in cerebral and cardiovascular diseases, inflammation, cancer, and their regulation","volume":"9","author":"Bernstein","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cpt.2025.12.003_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.etap.2011.12.023","article-title":"Let-7 g is involved in doxorubicin induced myocardial injury","volume":"33","author":"Fu","year":"2012","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib86","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biocel.2009.03.002","article-title":"MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease","volume":"42","author":"Townley-Tilson","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cpt.2025.12.003_bib87","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41390-020-1049-5","article-title":"Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment","volume":"89","author":"Cheung","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.livres.2020.06.001","article-title":"MiR-22 as a metabolic silencer and liver tumor suppressor","volume":"4","author":"Wang","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2019.10.140","article-title":"MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1","volume":"521","author":"Xu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cpt.2025.12.003_bib90","article-title":"The microRNA in ventricular remodeling: the miR-30 family","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12012-018-9457-z","article-title":"Serum miR-30c level predicted cardiotoxicity in non-small cell lung cancer patients treated with Bevacizumab","volume":"18","author":"Zhou","year":"2018","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpt.2025.12.003_bib92","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.healun.2012.03.010","article-title":"Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression","volume":"31","author":"Bockmeyer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpt.2025.12.003_bib93","first-page":"4987","article-title":"Let-7f and miRNA-126 correlate with reduced cardiotoxicity risk in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy","volume":"11","author":"Zhu","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cpt.2025.12.003_bib94","doi-asserted-by":"crossref","first-page":"214","DOI":"10.18632\/oncotarget.28182","article-title":"Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial","volume":"13","author":"Wanderley","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.cpt.2025.12.003_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.05.002","article-title":"Myeloperoxidase: a new player in autoimmunity","volume":"317","author":"Strzepa","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cpt.2025.12.003_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107150","article-title":"Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"43","author":"Yang","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cpt.2025.12.003_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2022.01.013","article-title":"Extracellular matrix remodeling in anthracycline-induced cardiotoxicity: what place on the pedestal?","volume":"350","author":"Grakova","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1396133","article-title":"GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy","volume":"15","author":"Tian","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib99","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.clinbiochem.2013.06.029","article-title":"Growth-differentiation factor-15 and tissue doppler \u0131maging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors","volume":"46","author":"Arslan","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cpt.2025.12.003_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.cpt.2025.12.003_bib101","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/08820139.2021.1882486","article-title":"Interleukin-10 levels are associated with doxorubicin-related cardiotoxicity in breast cancer patients in a one-year Follow-Up study","volume":"51","author":"Alves","year":"2022","journal-title":"Immunol Investig"},{"key":"10.1016\/j.cpt.2025.12.003_bib102","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40959-020-0058-1","article-title":"Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy","volume":"6","author":"Canada","year":"2020","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.cpt.2025.12.003_bib103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-012-2039-z","article-title":"High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study","volume":"134","author":"Onitilo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpt.2025.12.003_bib104","article-title":"Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy","volume":"13","author":"Singh","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib105","article-title":"Efficacy of Dexrazoxane in cardiac protection in pediatric patients treated with anthracyclines","volume":"15","author":"Rahimi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cpt.2025.12.003_bib106","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3892\/etm.2024.12715","article-title":"Myasthenia gravis and myocarditis induced by chemoimmunotherapy in locally advanced gastric cancer: a case report","volume":"28","author":"Wang","year":"2024","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810037","article-title":"Natural products counteracting cardiotoxicity during cancer chemotherapy: the special case of Doxorubicin, a comprehensive review","volume":"22","author":"Koss-Miko\u0142ajczyk","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib108","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1039\/D2FO03416F","article-title":"Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats","volume":"14","author":"Wu","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.cpt.2025.12.003_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153964","article-title":"Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cpt.2025.12.003_bib110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jare.2021.12.007","article-title":"Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity","volume":"40","author":"Liang","year":"2022","journal-title":"J Adv Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2273000","article-title":"Protective effect of Kaempferol and its nanoparticles on 5-Fluorouracil-Induced cardiotoxicity in rats","volume":"2022","author":"Safarpour","year":"2022","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.cpt.2025.12.003_bib112","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biopha.2017.08.118","article-title":"Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity","volume":"95","author":"Xu","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpt.2025.12.003_bib113","doi-asserted-by":"crossref","first-page":"65802","DOI":"10.1007\/s11356-021-15409-w","article-title":"Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats","volume":"28","author":"Abdulkareem Aljumaily","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.cpt.2025.12.003_bib114","doi-asserted-by":"crossref","first-page":"752","DOI":"10.21037\/cdt-19-707","article-title":"Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner","volume":"10","author":"Yu","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.cpt.2025.12.003_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116794","article-title":"Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway","volume":"482","author":"Chen","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119214","article-title":"Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK\/p53 signaling","volume":"10","author":"Thandavarayan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.12.003_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154130","article-title":"Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination","volume":"101","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cpt.2025.12.003_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032165","article-title":"KIT-5 structural and textural changes in response to different methods of functionalization with sulfonic groups","volume":"24","author":"Cha\u0142upniczak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib119","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2174\/1871520620666200619174323","article-title":"Encapsulation of imatinib in targeted KIT-5 nanoparticles for reducing its cardiotoxicity and hepatotoxicity","volume":"20","author":"Varshosaz","year":"2020","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.cpt.2025.12.003_bib120","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.1021\/acs.jafc.7b03627","article-title":"Release properties and cellular uptake in Caco-2 cells of size-controlled chitosan nanoparticles","volume":"65","author":"Je","year":"2017","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.cpt.2025.12.003_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110172","article-title":"The role of short-chain fatty acids in cancer prevention and cancer treatment","volume":"761","author":"Kalyanaraman","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cpt.2025.12.003_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/nano12030502","article-title":"Mollification of Doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid","volume":"12","author":"Siva","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.cpt.2025.12.003_bib123","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/acs.langmuir.4c04372","article-title":"H-Dots: Renal clearable zwitterionic nanocarriers for disease diagnosis and therapy","volume":"41","author":"Paranjape","year":"2025","journal-title":"Langmuir"},{"key":"10.1016\/j.cpt.2025.12.003_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015466","article-title":"H-Dot mediated nanotherapeutics mitigate systemic toxicity of platinum-based anticancer drugs","volume":"24","author":"Yamashita","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.cpt.2025.12.003_bib126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1039\/C4BM00272E","article-title":"Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer","volume":"3","author":"Scarano","year":"2015","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib127","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12012-021-09636-3","article-title":"The effect of curcumin nanoparticles on cisplatin-induced cardiotoxicity in Male Wistar albino rats","volume":"21","author":"Khadrawy","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpt.2025.12.003_bib128","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10557-021-07248-1","article-title":"The combination of beta-blockers and ACE inhibitors across the spectrum of cardiovascular diseases","volume":"37","author":"Strauss","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpt.2025.12.003_bib129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehab843","article-title":"A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer","volume":"43","author":"Lewinter","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpt.2025.12.003_bib130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00392-019-01448-4","article-title":"Cardioprotective effect of renin-angiotensin inhibitors and \u03b2-blockers in trastuzumab-related cardiotoxicity","volume":"108","author":"Ohtani","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CRD.0000000000000252","article-title":"The preventive role of angiotensin converting enzyme Inhibitors\/Angiotensin-II receptor blockers and \u03b2-Adrenergic blockers in Anthracycline- and trastuzumab-induced cardiotoxicity","volume":"27","author":"Blanter","year":"2019","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cpt.2025.12.003_bib132","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033295","article-title":"Allostatic load\/chronic stress and cardiovascular outcomes in patients diagnosed with breast, lung, or colorectal cancer","volume":"13","author":"Stabellini","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpt.2025.12.003_bib133","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.it.2022.12.003","article-title":"Risk factors of cytokine release syndrome: stress, catecholamines, and beyond","volume":"44","author":"Xing","year":"2023","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cpt.2025.12.003_bib134","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11906-015-0594-5","article-title":"Role of the sympathetic nervous system in stress-mediated cardiovascular disease","volume":"17","author":"Hering","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111366","article-title":"The interaction between metals and catecholamines: oxidative stress, DNA damage, and implications for human health","volume":"226","author":"Cassera","year":"2025","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.cpt.2025.12.003_bib136","first-page":"935","article-title":"Effects of relaxation training combined with music-based intervention on anxiety and depression in patients undergoing hematopoietic stem cell transplantation: a quasi-experimental study","volume":"33","author":"Xia","year":"2025","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cpt.2025.12.003_bib137","first-page":"1","article-title":"Characterizing alterations in cortisol secretion during cardiac surgery","volume":"2023","author":"Raju","year":"2023","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.cpt.2025.12.003_bib138","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12888-025-06727-1","article-title":"The depression-heart connection: cardiovascular risks in cancer patients from NHANES 2005-2018","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cpt.2025.12.003_bib140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10253890.2022.2104121","article-title":"Juvenile exposure to doxorubicin alters the cardiovascular response to adult-onset psychosocial stress in mice","volume":"25","author":"Grant","year":"2022","journal-title":"Stress"},{"key":"10.1016\/j.cpt.2025.12.003_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113706","article-title":"Mitochondrial dysfunction in the development and progression of cardiometabolic diseases: a narrative review","volume":"14","author":"Pliouta","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib142","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000512117","article-title":"N-Acetylcysteine attenuates the anxiety-like behavior and spatial cognition impairment induced by doxorubicin and cyclophosphamide combination treatment in rats","volume":"106","author":"Kitamura","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.cpt.2025.12.003_bib143","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaccao.2022.09.008","article-title":"The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis","volume":"5","author":"Klimis","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143549","article-title":"Activation of sigma 1 receptor attenuates doxorubicin-induced cardiotoxicity by alleviating oxidative stress, mitochondria dysfunction, ER stress-related apoptosis, and autophagy impairment","volume":"310","author":"Al-Maamari","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cpt.2025.12.003_bib145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11095-019-2746-9","article-title":"The risk of QTc-Interval prolongation in breast cancer patients treated with tamoxifen in combination with serotonin reuptake inhibitors","volume":"37","author":"Hussaarts","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib146","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/ATVBAHA.124.319866","article-title":"Radiation-induced macrovessel\/microvessel disease","volume":"44","author":"Abe","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpt.2025.12.003_bib147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.rpor.2019.09.002","article-title":"Cardiotoxicity of mediastinal radiotherapy","volume":"24","author":"Ratosa","year":"2019","journal-title":"Rep Practical Oncol Radiother"},{"key":"10.1016\/j.cpt.2025.12.003_bib148","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40959-023-00175-0","article-title":"Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic review","volume":"9","author":"Omidi","year":"2023","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.cpt.2025.12.003_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115401","article-title":"A comprehensive review of radiotherapy-induced coronary artery disease-epidemiology, biological mechanisms, and preventive strategies","volume":"26","author":"Daher","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib150","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.cpt.2025.12.003_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cpt.2025.12.003_bib152","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cpt.2025.12.003_bib153","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cpt.2025.12.003_bib154","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cpt.2024.04.004","article-title":"Cardiotoxicity in platinum-based chemotherapy: mechanisms, manifestations, and management","volume":"3","author":"Rachma","year":"2025","journal-title":"Cancer Pathog Ther"},{"key":"10.1016\/j.cpt.2025.12.003_bib155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cpt.2023.02.002","article-title":"Evolving field of cardio-oncology","volume":"1","author":"Li","year":"2023","journal-title":"Cancer Pathog Ther"},{"key":"10.1016\/j.cpt.2025.12.003_bib156","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/hm.HM-D-24-00068","article-title":"From heart to mind: research advances in the link between coronary artery disease and mental stress \u2013 a narrative review","volume":"vol. 9","author":"Li","year":"2025","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2025.12.003_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1047700","article-title":"Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy","volume":"9","author":"Lv","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2023.08.032","article-title":"A meta-analysis on the association between SSRIs and blood pressure in patients with CVD and depression","volume":"340","author":"Zhang","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.cpt.2025.12.003_bib159","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11864-019-0658-x","article-title":"Pediatric cardio-oncology: Development of cancer treatment-related cardiotoxicity and the therapeutic approach to affected patients","volume":"20","author":"Ryan","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1074248420968689","article-title":"Age-related considerations in cardio-oncology","volume":"26","author":"Screever","year":"2021","journal-title":"J Cardiovasc Pharmacol Therapeut"},{"key":"10.1016\/j.cpt.2025.12.003_bib161","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib162","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/hm.HM-D-23-00021","article-title":"Multiomics on mental stress-induced myocardial ischemia: a narrative review","volume":"8","author":"Jin","year":"2024","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2025.12.003_bib163","first-page":"3381","article-title":"Multi-omics research on angina pectoris: a novel perspective","volume":"16","author":"Chen","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.cpt.2025.12.003_bib164","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1536\/ihj.23-302","article-title":"Single-cell transcriptomic analysis reveals myocardial fibrosis mechanism of doxorubicin-induced cardiotoxicity","volume":"65","author":"Huyan","year":"2024","journal-title":"Int Heart J"},{"key":"10.1016\/j.cpt.2025.12.003_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2025.111087","article-title":"Exploring the mechanism of action of trastuzumab-induced cardiomyocyte atrophy based on the FN1\/PI3K\/AKT-mediated mTOR-independent signaling pathway","volume":"117","author":"Zhu","year":"2025","journal-title":"Genomics"},{"key":"10.1016\/j.cpt.2025.12.003_bib166","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/hm.HM-D-24-00045","article-title":"Effects of Tai Chi and Qigong on heart rate variability: a systematic review and meta-analysis","volume":"8","author":"Larkey","year":"2024","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2025.12.003_bib167","article-title":"A rare case of ciprofloxacin-induced bradycardia recognized by a smartwatch","volume":"10","author":"Cordova Sanchez","year":"2022","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70155","article-title":"Managing doxorubicin cardiotoxicity: insights into molecular mechanisms and protective strategies","volume":"39","author":"Al Khafaji","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.cpt.2025.12.003_bib169","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cpt.2025.12.003_bib170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2020.8016","article-title":"Cardiac damage in anthracyclines therapy: focus on oxidative stress and inflammation","volume":"32","author":"Rocca","year":"2020","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.cpt.2025.12.003_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030520","article-title":"Mitochondrial determinants of anti-cancer drug-induced cardiotoxicity","volume":"10","author":"Rocca","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cpt.2025.12.003_bib172","article-title":"Understanding anthracycline cardiotoxicity from mitochondrial aspect","volume":"13","author":"Huang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib173","article-title":"Novel mechanisms of anthracycline-induced cardiovascular toxicity: a focus on thrombosis, cardiac atrophy, and programmed cell death","volume":"8","author":"Antoniak","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib174","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000512771","article-title":"Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction","volume":"146","author":"Grakova","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.cpt.2025.12.003_bib175","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cpt.2025.12.003_bib176","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-020-0719-1","article-title":"Cardiotoxicities of 5-Fluorouracil and other fluoropyrimidines","volume":"21","author":"Shiga","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib177","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11912-016-0521-1","article-title":"Fluoropyrimidine-induced cardiotoxicity: manifestations, mechanisms, and management","volume":"18","author":"Layoun","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib178","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2050-6511-15-47","article-title":"A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity","volume":"15","author":"Polk","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cpt.2025.12.003_bib179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115686","article-title":"Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes","volume":"10","author":"Focaccetti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.12.003_bib180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jcu.23388","article-title":"Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients","volume":"51","author":"Mihalcea","year":"2023","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.cpt.2025.12.003_bib181","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0936-6555(05)80452-2","article-title":"Acute myocardial infarction following paclitaxel administration for ovarian carcinoma","volume":"9","author":"Laher","year":"1997","journal-title":"Clin Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib182","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10157-024-02490-x","article-title":"An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management","volume":"28","author":"Oliveira","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.cpt.2025.12.003_bib183","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4965171","article-title":"The role of antioxidants in ameliorating cyclophosphamide-induced cardiotoxicity","volume":"2020","author":"Ayza","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cpt.2025.12.003_bib184","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12012-014-9247-1","article-title":"Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models","volume":"14","author":"Sayed-Ahmed","year":"2014","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpt.2025.12.003_bib185","doi-asserted-by":"crossref","first-page":"ytae365","DOI":"10.1093\/ehjcr\/ytae365","article-title":"An acute coronary syndrome in an unusual patient: analysing cisplatin toxicity-a case report and review of the literature","volume":"8","author":"Erquicia","year":"2024","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib186","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejphar.2016.09.013","article-title":"Intracellular zinc status influences cisplatin-induced endothelial permeability through modulation of PKC\u03b1, NF-\u03baB and ICAM-1 expression","volume":"791","author":"Bodiga","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cpt.2025.12.003_bib187","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-021-06280-x","article-title":"Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies","volume":"188","author":"Dempsey","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpt.2025.12.003_bib188","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/CIRCRESAHA.121.318223","article-title":"Heart failure with targeted cancer therapies: mechanisms and cardioprotection","volume":"128","author":"Hahn","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cpt.2025.12.003_bib189","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/CS20200305","article-title":"Cardiotoxic effects of angiogenesis inhibitors","volume":"135","author":"Dobbin","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cpt.2025.12.003_bib190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/10781552211073823","article-title":"Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma","volume":"28","author":"Bardaro","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.cpt.2025.12.003_bib191","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2015.08.003","article-title":"In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib","volume":"80","author":"Sundby","year":"2015","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.cpt.2025.12.003_bib192","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","article-title":"Immune checkpoint inhibitor-induced cardiotoxicity: a systematic review and meta-analysis","volume":"10","author":"Nielsen","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cpt.2025.12.003_bib193","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11912-021-01070-6","article-title":"Cardiotoxicity of immune checkpoint inhibitors","volume":"23","author":"Patel","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.cpt.2025.12.003_bib194","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpt.2025.12.003_bib195","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/NCC.0000000000001274","article-title":"Effectiveness of internet-based cognitive behavioral therapy for patients with cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Yu","year":"2025","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.cpt.2025.12.003_bib196","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pon.3648","article-title":"Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors","volume":"24","author":"Johns","year":"2015","journal-title":"Psychooncology"},{"key":"10.1016\/j.cpt.2025.12.003_bib197","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000515756","article-title":"Effectiveness of supportive-expressive group therapy in women with breast cancer: a systematic review and meta-analysis","volume":"44","author":"Lai","year":"2021","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.cpt.2025.12.003_bib198","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08964289.2018.1452713","article-title":"Acceptance and commitment therapy in cancer: review of applications and findings","volume":"45","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2019","journal-title":"Behav Med"},{"key":"10.1016\/j.cpt.2025.12.003_bib199","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pon.5561","article-title":"Acute effects of aerobic exercise and relaxation training on fatigue in breast cancer survivors: a feasibility trial","volume":"30","author":"Cohen","year":"2021","journal-title":"Psychooncology"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294971322500117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294971322500117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:26:36Z","timestamp":1790886396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294971322500117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":199,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S294971322500117X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2025.12.003","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer therapy-induced cardiotoxicity: mechanisms, biomarkers, psychological stress, and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2025.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}